MedTrace Logo

Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping

NCT05140915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2025-09-04

Study results available
· View outcomes & findings →

Summary

The dramatic increase in the use of e-cigarettes among U.S. adolescents has been called a national epidemic, with more adolescents now using e-cigarettes than traditional cigarettes. The high amounts of nicotine in e-cigarettes harm adolescents and put them at greater risk of becoming traditional cigarette smokers. The investigators propose to develop Vaper-to-Vaper (V2V), a suite of mobile peer driven tools including peer texting and coaching based on lessons learned in the investigators' prior tobacco intervention work, to engage and help adolescents use strategies to manage cravings and successfully quit.

Conditions

  • E-cigarette Use
  • Vaping

Interventions

BEHAVIORAL

Peer Messaging

Peer messages, written by current and former adolescent e-cigarette users and tailored by age and readiness-to-quit.

BEHAVIORAL

Peer Coaching via Text

Peer coaching, facilitated by texting

BEHAVIORAL

Gamification

Gamification, designed to motivate participation

OTHER

E-Cigarette Cessation Materials

E-cigarette cessation materials by the Research Coordinator at the time of study enrollment.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Rajani Sadasivam, PhD · University of Massachusetts Chan Medical School

  • Lori Pbert, PhD · University of Massachusetts Chan Medical School

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-19
Primary Completion
2023-06-09
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140915 on ClinicalTrials.gov